Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (31)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kang, K. S.
Right arrow Articles by Chang, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kang, K. S.
Right arrow Articles by Chang, C. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol 18, 251-257, Copyright © 1997 by Oxford University Press

ARTICLES

Expression of estrogen receptors in a normal human breast epithelial cell type with luminal and stem cell characteristics and its neoplastically transformed cell lines

KS Kang, I Morita, A Cruz, YJ Jeon, JE Trosko and CC Chang
Department of Pediatrics/Human Development, College of Human Medicine, Michigan State University, East Lansing 48824-1317, USA.

Although approximately two-thirds of breast cancers are estrogen receptor (ER)-positive, only a small proportion of epithelial cells in the mammary gland express the ER. The origin of the ER-positive breast cancers is unknown. Recently, we have developed a culture method to grow two morphologically and antigenically distinguishable types of normal human breast epithelial cells (HBEC) derived from reduction mammoplasty. In this report, we studied the expression of ER in these two types of cells and their transformed cell lines. The results indicate that Type I HBEC with luminal and stem cell characteristics expressed a variant ER (approximately 48 kd) by Western blot analysis. This variant ER contains a deletion in the DNA binding domain (exon 2) as revealed by RT-PCR analysis. The lack of the DNA-binding domain of the variant ER was also confirmed by the ER-estrogen responsive element binding assay, as well as by the immunofluorescence staining of the ER using anti-ER antibodies which recognize either the C-terminal or N- terminal region. In contrast, Type II HBEC with basal epithelial phenotype are ER-negative. Simian virus 40 (SV40) transformed Type I and Type II HBEC lines also expressed the variant ER. Tumors formed in athymic nude mice by in vitro transformed tumorigenic Type I cell lines, however, expressed a high level of wild type ER which was undetectable in these cells grown in vitro before and after tumor formation. Thus, there appears to be a differential ER mRNA splicing between the in vitro and in vivo mileu.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CarcinogenesisHome page
F. L. Muehlberg, Y.-H. Song, A. Krohn, S. P. Pinilla, L. H. Droll, X. Leng, M. Seidensticker, J. Ricke, A. M. Altman, E. Devarajan, et al.
Tissue-resident stem cells promote breast cancer growth and metastasis
Carcinogenesis, April 1, 2009; 30(4): 589 - 597.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
R. Villadsen, A. J. Fridriksdottir, L. Ronnov-Jessen, T. Gudjonsson, F. Rank, M. A. LaBarge, M. J. Bissell, and O. W. Petersen
Evidence for a stem cell hierarchy in the adult human breast
J. Cell Biol., April 9, 2007; 177(1): 87 - 101.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
E. H. Ahn, C.-C. Chang, and J. J. Schroeder
Evaluation of sphinganine and sphingosine as human breast cancer chemotherapeutic and chemopreventive agents.
Experimental Biology and Medicine, November 1, 2006; 231(10): 1664 - 1672.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Ponti, A. Costa, N. Zaffaroni, G. Pratesi, G. Petrangolini, D. Coradini, S. Pilotti, M. A. Pierotti, and M. G. Daidone
Isolation and In vitro Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties
Cancer Res., July 1, 2005; 65(13): 5506 - 5511.
[Abstract] [Full Text] [PDF]

Home page
 J DAIRY SCIHome page
M. S. Holland and R. E. Holland
The Cellular Perspective on Mammary Gland Development: Stem/Progenitor Cells and Beyond
J Dairy Sci, May 1, 2005; 88(e_suppl_1): E1 - E8.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
I.-S. Hong, S.-H. Kim, M. K. Koong, J. H. Jun, S.-H. Kim, Y.-S. Lee, and K.-S. Kang
Roles of p38 and c-jun in the differentiation, proliferation and immortalization of normal human endometrial cells
Hum. Reprod., October 1, 2004; 19(10): 2192 - 2199.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. J. Miksicek, Y. Myal, P. H. Watson, C. Walker, L. C. Murphy, and E. Leygue
Identification of a Novel Breast- and Salivary Gland-specific, Mucin-like Gene Strongly Expressed in Normal and Tumor Human Mammary Epithelium
Cancer Res., May 1, 2002; 62(10): 2736 - 2740.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
W. Sun, K.-S. Kang, I. Morita, J. E. Trosko, and C.-C. Chang
High Susceptibility of a Human Breast Epithelial Cell Type with Stem Cell Characteristics to Telomerase Activation and Immortalization
Cancer Res., December 1, 1999; 59(24): 6118 - 6123.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.